≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Disorders of muscle tone of newborn

Endpoint Browser PheWeb

P16_DISORD_MUSCLE_TONE_NEWBO

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — P94
  • Cause of death: ICD-10 — P94

2 out of 7 registries used, show all original rules.

62

4. Check minimum number of events

None

62

5. Include endpoints

None

62

6. Filter based on genotype QC (FinnGen only)

62

Control definitions (FinnGen only)

Control exclude
P16_OTH_DISORD_ORIGINA_PERINA_PERIOD

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
P9
Name in latin
Dystonia muscularis neonati

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 2823 1183 1638
Only index persons 1569 650 919
Unadjusted period prevalence (%)
Whole population 0.04 0.03 0.05
Only index persons 0.03 0.02 0.04
Median age at first event (years)
Whole population 0.24 0.19 0.19
Only index persons 0.33 0.36 0.31

-FinnGen-

Key figures

All Female Male
Number of individuals 62 29 33
Unadjusted period prevalence (%) 0.01 0.01 0.01
Median age at first event (years) 0.43 0.51 0.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
56
Matched controls
558
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P94.2
ICD-10 Finland
Congenital hypotonia
+∞
36.5
31
*
P94.1
ICD-10 Finland
Congenital hypertonia
+∞
13.0
12
*
R62.0
ICD-10 Finland
Delayed milestone
9.4
9.3
20
31
F79.0
ICD-10 Finland
Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour
33.5
8.9
11
*
P94.9
ICD-10 Finland
Disorder of muscle tone of newborn, unspecified
+∞
8.5
8
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
9.3
7.3
15
21
P85
ICPC
Mental retardation
26.2
6.9
9
*
R62.8
ICD-10 Finland
Other lack of expected normal physiological development
17.0
6.7
10
7
P94.8
ICD-10 Finland
Other disorders of muscle tone of newborn
+∞
6.4
6
*
F79.9
ICD-10 Finland
Unspecified mental retardation, without mention of impairment of behaviour
+∞
6.4
6
*
R4110
NOMESCO Finland
Physiotherapy
4.4
6.3
28
103
Z3226
NOMESCO Finland
Physiotherapist
4.4
6.1
26
92

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3044640) Blood type and Crossmatch panel - Blood
28
142
2.77
3.68
5.6
3.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
6
8.92
2.80
2.8
1.0
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
31
191
2.25
2.47
6.6
4.3
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
7
17
4.50
2.44
3.3
1.8
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
20
105
2.34
2.29
4.5
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
5
9
5.93
2.25
5.6
3.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
54
442
2.72
2.17
25.5
16.7
mmol/l
4.0
4.0
0.14
54
425
(3019550) Sodium [Moles/volume] in Serum or Plasma
54
443
2.69
2.16
23.4
16.8
mmol/l
139.2
139.3
0.14
54
430
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
24
141
2.15
2.09
9.2
15.5
mmol/l
0.0
0.9
0.67
17
105
(3015736) pH of Urine
26
160
2.08
1.99
5.3
4.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
16
4.03
1.98
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
16
4.03
1.98
1.3
1.4
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
26
163
2.02
1.88
5.7
4.8
e6/l
11.5
37.8
0.80
19
127
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
35
244
2.00
1.88
13.5
19.2
mmol/l
1.2
1.2
0.03
35
229
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
21
122
2.09
1.85
7.0
3.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
5
13
4.08
1.75
1.6
4.6
—
—
—
0
0
(3012544) pH of Venous blood
21
125
2.03
1.72
9.2
13.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
36
259
1.93
1.71
20.5
7.3
ml/min/173m2
108.7
106.8
0.12
23
177
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
23
143
1.97
1.67
10.9
21.1
mmol/l
24.2
24.6
0.32
23
143
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
38
280
1.92
1.66
11.0
5.5
u/l
129.6
128.7
0.02
38
262
(40758558) Short blood count panel - Blood
27
178
1.92
1.65
8.5
8.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
44
341
2.00
1.65
4.0
3.1
pmol/l
14.4
14.5
0.07
36
311
(3041096) Erythrocytes [Presence] in Urine by Automated
18
103
2.05
1.63
4.7
4.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
11
51
2.41
1.62
1.8
1.8
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
121
0.36
1.60
2.2
2.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
23
146
1.91
1.56
5.3
4.3
e6/l
0.1
0.1
0.23
16
110
(36304419) Bacteria [Presence] in Urine
23
148
1.88
1.49
4.7
4.3
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
22
2.91
1.47
2.5
1.8
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
68
2.15
1.46
1.8
2.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
126
1.87
1.36
9.4
14.7
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
10
48
2.29
1.36
3.1
6.8
%
150.3
160.2
—
10
48
(3000991) Gas panel - Venous blood
19
118
1.88
1.35
10.3
14.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
29
206
1.77
1.34
8.8
5.7
estimate
0.0
0.0
—
5
42
(3037467) Urinalysis macro (dipstick) panel - Urine
38
293
1.77
1.32
5.9
4.5
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
5
18
2.93
1.31
1.2
1.9
g/l
63.9
59.4
—
5
18
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
25
171
1.77
1.31
6.2
4.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
21
137
1.81
1.28
4.4
4.2
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
27
191
1.73
1.25
8.0
5.7
e6/l
19.8
29.8
0.38
19
129
(40761511) CBC panel - Blood by Automated count
54
471
2.13
1.25
14.1
9.7
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
19
2.77
1.24
17.8
11.0
%
60.5
54.3
—
5
19
(3021901) Oxygen saturation in Capillary blood
5
19
2.77
1.24
3.8
17.0
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
29
210
1.72
1.23
5.3
4.1
estimate
0.0
0.0
—
5
43
(3012516) Albumin [Mass/volume] in Urine
8
39
2.20
1.20
5.5
2.9
mg/l
64.0
95.5
—
8
29
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
30
2.50
1.16
1.3
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
7
32
2.33
1.12
2.4
2.0
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
7
32
2.33
1.12
21.6
6.0
g/l
0.4
0.3
—
7
26
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
24
171
1.66
1.05
6.8
3.9
nmol/l
66.7
69.6
0.27
24
160
(40761536) Microorganisms panel - Urine sediment
7
35
2.12
1.04
3.3
3.3
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
31
237
1.62
1.03
10.7
11.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
7
130
0.48
1.02
2.1
2.5
—
—
—
0
0
(3013512) EKG study
9
51
1.89
1.00
3.6
2.7
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
0
32
0.00
0.98
0.0
1.3
—
—
—
0
0
(3002256) Pathology report gross observation
7
37
2.00
0.97
1.3
1.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
71
1.86
0.97
1.3
2.3
—
—
—
0
0
(3000492) Spirometry study
6
29
2.18
0.92
2.2
1.3
—
—
—
0
0
(4035726)
6
29
2.18
0.92
1.5
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
52
459
1.82
0.92
12.2
8.9
u/l
27.0
24.9
0.32
52
442
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
19
132
1.63
0.90
10.4
13.0
mmol/l
23.4
24.2
1.42
19
132
(3026008) Bacteria identified in Urine by Culture
17
116
1.64
0.86
1.8
2.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
9
142
0.57
0.82
2.3
2.0
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
9
52
1.85
0.81
1.3
1.8
—
462.2
—
0
9
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
54
1.78
0.79
1.9
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
9
55
1.74
0.78
1.9
2.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
37
308
1.50
0.77
11.1
11.1
e9/l
0.2
0.2
0.56
32
254
(3001604) Monocytes [#/volume] in Blood
36
299
1.49
0.75
10.9
10.3
e9/l
0.6
0.6
0.14
31
245
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
54
490
1.79
0.74
21.3
13.0
mg/l
22.3
22.6
0.02
41
357
(3006315) Basophils [#/volume] in Blood
36
300
1.48
0.73
10.9
10.2
e9/l
0.0
0.0
0.36
31
246
(3022145) Colonoscopy Study observation
5
26
2.00
0.72
1.4
1.7
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
37
312
1.46
0.69
10.9
10.0
e9/l
3.4
2.4
0.45
31
261
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
14
96
1.59
0.69
4.9
3.8
e6/l
1.0
0.4
—
7
59
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
28
224
1.46
0.69
3.5
4.7
u/l
50.6
31.6
0.48
28
211
(3024891) Influenza virus A+B Ag [Presence] in Specimen
5
28
1.85
0.67
1.0
1.2
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
35
293
1.45
0.67
11.5
10.4
%
2.4
3.2
1.42
35
281
(3007164) IgA [Mass/volume] in Serum or Plasma
26
206
1.45
0.67
1.7
1.6
g/l
1.5
1.5
0.08
14
107
(3026782) Osmolality of Urine
14
97
1.57
0.66
4.6
3.6
mosm/kgh2o
557.1
580.4
0.17
14
83
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
18
234
0.67
0.65
2.1
2.1
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
98
1.55
0.63
1.3
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
35
296
1.42
0.62
11.7
10.4
%
7.4
8.4
1.21
35
287
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
86
0.55
0.62
2.6
2.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
20
0.00
0.61
0.0
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
0
20
0.00
0.61
0.0
1.7
—
5.0
—
0
14
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
19
0.00
0.61
0.0
1.2
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
22
0.00
0.60
0.0
1.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
0
22
0.00
0.60
0.0
1.0
—
—
—
0
0
(40761535) Cells panel - Urine sediment
0
23
0.00
0.59
0.0
3.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
23
0.00
0.59
0.0
1.9
—
—
—
0
0
(3044889) 12 lead EKG panel
24
191
1.42
0.59
2.3
2.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
14
100
1.52
0.58
5.1
4.0
e6/l
0.7
2.5
—
8
64
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
44
484
0.69
0.58
3.3
3.9
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
38
329
1.40
0.57
13.7
11.9
e9/l
4.3
3.7
0.75
33
272
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
9
61
1.55
0.57
3.1
12.5
%
94.1
89.7
—
9
61
(3003694) ABO and Rh group [Type] in Blood
21
165
1.41
0.55
1.7
1.7
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
6
40
1.55
0.53
2.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
70
1.51
0.45
1.0
1.1
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
10
70
1.51
0.45
5.5
6.8
umol/l
6.0
5.8
—
10
64
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
15
0.00
0.42
0.0
4.5
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
0
17
0.00
0.41
0.0
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
10
72
1.46
0.40
3.8
21.8
mmol/l
1.8
1.3
—
10
63
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
76
0.63
0.38
1.0
2.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
7
51
1.42
0.33
1.3
1.4
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
13
103
1.33
0.31
3.5
4.1
kg/l
1.0
1.0
—
5
15
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
11
85
1.36
0.30
1.8
1.5
pmol/l
97.5
94.9
—
6
46
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
73
0.66
0.28
2.6
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
9
76
1.22
0.26
2.8
2.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
33
301
1.21
0.24
16.7
11.4
e9/l
0.4
0.0
0.49
27
229
(40768804) Tissue Pathology biopsy report
14
117
1.25
0.23
1.9
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
5
41
1.24
0.22
1.4
1.3
—
7.4
—
0
15
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
9
110
0.79
0.22
1.6
1.7
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
11
0.00
0.21
0.0
4.9
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
0
11
0.00
0.21
0.0
1.4
—
5.7
—
0
6
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.5
—
30.0
—
0
10
(3001019) Free T4 and TSH panel - Serum or Plasma
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
50
484
1.17
0.12
25.0
18.4
%
38.5
38.6
0.06
43
432
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
5
44
1.15
0.10
1.0
1.0
mmol/l
20.6
19.3
—
5
44
(3006598) pH of Arterial cord blood
5
44
1.15
0.10
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
7
79
0.87
0.07
1.7
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
11
100
1.12
0.05
5.8
5.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
13
120
1.11
0.05
5.3
3.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
14
143
0.97
0.00
1.5
2.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.1
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
0
9
0.00
0.00
0.0
1.1
—
205.9
—
0
9
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
4.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.2
—
7.8
—
0
9
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
34.4
—
0.7
—
0
5
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
0.3
—
0
7
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
0
5
0.00
0.00
0.0
1.0
—
12.6
—
0
5
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017461) Flecainide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
5.2
—
0.5
—
0
6
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
96.8
—
0
6
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
12.8
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
9
0.00
0.00
0.0
5.4
—
4.4
—
0
9
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
5
0.00
0.00
0.0
8.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.3
—
6.7
—
0
6
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
3.1
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
14.3
—
9.5
—
0
8
(4094501)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
12.8
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.2
—
0.6
—
0
5

Mortality – FinRegistry

↥

Association

Association between endpoint P16_DISORD_MUSCLE_TONE_NEWBO and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have P16_DISORD_MUSCLE_TONE_NEWBO.

N-year risk Females Males
1 No data No data
5 No data No data
10 No data No data
15 No data No data
20 No data No data

Relationships between endpoints

↥

Index endpoint: P16_DISORD_MUSCLE_TONE_NEWBO – Disorders of muscle tone of newborn

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data